✦Limited Time Offer✦$99 GLP-1 Injections: While Supplies Last✦
2026 Subscription Fee Audit

Telehealth FX vs Mochi Health: The Real Cost of GLP-1 Memberships

Julian Mercer, M.S.
Julian Mercer, M.S. · Clinical Healthcare Economics
Provider Pricing Audit · Updated September 2026 · 12 min read
Frosted glass pharmaceutical bottle on architectural black slate beside titanium caliper and antique brass balance scale
Editorial Still Life · Archival Photographic Standard
Direct Comparative Resolution

Telehealth FX provides compounded semaglutide for $146/month and tirzepatide for $258/month across all doses with zero membership fees. In contrast, Mochi Health requires an obligatory $79 monthly membership fee ($948 annually) on top of medication costs ($175–$275/mo), making Telehealth FX substantially more affordable for long-term weight management.

Cost Breakdown: Telehealth FX vs Mochi Health

While Mochi advertises lower medication base prices, their mandatory subscription structure significantly inflates the actual monthly cost:

Cost ElementTelehealth FXMochi Health
Monthly Membership Subscription$0 / month (No Dues)$79 / month ($948/yr mandatory)
Compounded Semaglutide Total OutlayFlat $146/mo ($99 Month 1)$175 med + $79 fee = $254/month
Compounded Tirzepatide Total OutlayFlat $258/mo ($99 Month 1)$275 med + $79 fee = $354/month
Doctor Consultations & Follow-Ups100% Free & UnlimitedIncluded in $79/mo subscription
Cold-Chain Express ShippingFree 2-Day ShippingIncluded
12-Month Total Outlay (Semaglutide)$1,705 Total$3,048 Total ($1,343 More)
12-Month Total Outlay (Tirzepatide)$2,937 Total$4,248 Total ($1,311 More)
Switch from Mochi Health

Stop Paying the $79 Monthly Membership Fee

Why pay an extra $948 per year just to access a telehealth portal? Transfer your prescription to Telehealth FX today. Upload your current vial to match your dose at flat $146/mo (Semaglutide) or $258/mo (Tirzepatide).

Transfer from Mochi ($99 Promo Month 1)

Why Subscription Membership Models Harm Long-Term Patient Compliance

Obesity and metabolic resistance are chronic, biological conditions requiring consistent incretin therapy over 12 to 24 months. When telehealth clinics impose separate membership dues, patients often stop medication prematurely due to subscription fatigue rather than clinical completion.

By decoupling medical care from recurring SaaS fees, Telehealth FX ensures patients can remain on their therapeutic maintenance doses as long as clinically indicated without accumulating unnecessary subscription overhead.

Experience True Telehealth Transparency

Zero membership traps, zero consultation fees, and flat-rate compounded medications formulated in licensed 503A US compounding pharmacies.

Check Your Eligibility Now